Inventor
PERNI ROBERT B
US55 patents
⚠️ This page may combine multiple inventors who share the name “PERNI ROBERT B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
12 patentsUS7208600B2Apr 24, 2007
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
VERTEX PHARMA129 citations98
US7273885B2Sep 25, 2007
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA78 citations97
US7378422B2May 27, 2008
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA39 citations95
US7109172B2Sep 19, 2006
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA42 citations95
US6909000B2Jun 21, 2005
Bridged bicyclic serine protease inhibitors
VERTEX PHARMA78 citations95
US7365092B2Apr 29, 2008
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA40 citations92
US7820671B2Oct 26, 2010
Peptidomimetic protease inhibitors
VERTEX PHARMA33 citations90
US7241796B2Jul 10, 2007
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA40 citations90
US7906550B2Mar 15, 2011
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA7 citations84
US8039623B2Oct 18, 2011
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA5 citations62
US7745444B2Jun 29, 2010
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA3 citations61
US7767680B2Aug 3, 2010
Ion channel modulators and methods of use
VERTEX PHARMA0 citations51
ATAI THERAPEUTICS INC
4 patentsUS12065405B2Aug 20, 2024
Prodrugs and conjugates of dimethyltryptamine
ATAI THERAPEUTICS INC4 citations73
US12012381B2Jun 18, 2024
Dimethyltryptamine analogues as nitric oxide delivery drugs
ATAI THERAPEUTICS INC4 citations73
US12344570B2Jul 1, 2025
Aminotetraline activators of serotonin receptors
ATAI THERAPEUTICS INC0 citations61
US12351537B2Jul 8, 2025
Dimethoxyphenylalkylamine activators of serotonin receptors
ATAI THERAPEUTICS INC0 citations57
ATAI Life Sciences AG
3 patentsUS11643391B2May 9, 2023
Prodrugs and conjugates of dimethyltryptamine
ATAI Life Sciences AG7 citations83
US11912680B2Feb 27, 2024
Nitric oxide releasing prodrugs of MDA and MDMA
ATAI Life Sciences AG3 citations72
US11827580B2Nov 28, 2023
Aminotetraline activators of serotonin receptors
ATAI Life Sciences AG4 citations72
STERLING WINTHROP INC
3 patentsGLAXOSMITHKLINE LLC
3 patentsUS9834558B2Dec 5, 2017
Substituted bridged urea analogs as sirtuin modulators
GLAXOSMITHKLINE LLC2 citations71
US9765075B2Sep 19, 2017
Substituted bridged urea analogs as sirtuin modulators
GLAXOSMITHKLINE LLC2 citations71
US10590135B2Mar 17, 2020
Substituted bridged urea analogs as sirtuin modulators
GLAXOSMITHKLINE LLC0 citations50
VU CHI B
3 patentsUS8685970B2Apr 1, 2014
Quinolines and related analogs as sirtuin modulators
VU CHI B7 citations68
US8846947B2Sep 30, 2014
Benzimidazoles and related analogs as sirtuin modulators
VU CHI B1 citations51
US9326986B2May 3, 2016
Quinazolinone, quinolone and related analogs as sirtuin modulators
VU CHI B1 citations50
PERNI ROBERT B
3 patentsGLAXOSMITHKLINE IP NO 2 LTD
2 patentsEMPATHBIO INC
2 patentsFARMER LUC J
2 patentsMARTINBOROUGH ESTHER
2 patentsTOTUS MEDICINES INC
2 patentsSIRTRIS PHARMACEUTICALS INC
1 patentBABINE ROBERT EDWARD
1 patentOALMANN CHRISTOPHER
1 patentENTHEOGENIX BIOSCIENCES INC
1 patentBRITT SHAWN D
1 patentBEMIS JEAN
1 patentCOTTRELL KEVIN M
1 patentSIRTRIS PHARMACEUTICALS
1 patentIMMUNOMOLECULAR THERAPEUTICS INC
1 patentShowing the top 50 of 55 patents by PatentIndex Score.